BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12457441)

  • 1. Novel therapies for narcolepsy.
    Brooks S; Black J
    Expert Opin Investig Drugs; 2002 Dec; 11(12):1821-7. PubMed ID: 12457441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging treatments for narcolepsy and its related disorders.
    Nishino S; Okuro M
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):139-58. PubMed ID: 20166851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging drugs for narcolepsy.
    Abad VC; Guilleminault C
    Expert Opin Emerg Drugs; 2004 Nov; 9(2):281-91. PubMed ID: 15571485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological management of narcolepsy with and without cataplexy.
    Kallweit U; Bassetti CL
    Expert Opin Pharmacother; 2017 Jun; 18(8):809-817. PubMed ID: 28443381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Narcolepsy: a new perspective on diagnosis and treatment].
    Fronczek R; van der Zande WL; van Dijk JG; Overeem S; Lammers GJ
    Ned Tijdschr Geneeskd; 2007 Apr; 151(15):856-61. PubMed ID: 17472116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium oxybate for excessive daytime sleepiness in narcolepsy-cataplexy.
    Arnulf I; Mignot E
    Sleep; 2004 Nov; 27(7):1242-3. PubMed ID: 15586777
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism of action of narcolepsy medications.
    Gowda CR; Lundt LP
    CNS Spectr; 2014 Dec; 19 Suppl 1():25-33; quiz 25-7, 34. PubMed ID: 25403789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of sodium oxybate as a treatment option for narcolepsy.
    Abad VC
    Expert Opin Pharmacother; 2019 Jul; 20(10):1189-1199. PubMed ID: 31136215
    [No Abstract]   [Full Text] [Related]  

  • 9. Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice.
    Mieda M; Willie JT; Hara J; Sinton CM; Sakurai T; Yanagisawa M
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4649-54. PubMed ID: 15070772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions.
    Zeitzer JM; Nishino S; Mignot E
    Trends Pharmacol Sci; 2006 Jul; 27(7):368-74. PubMed ID: 16766052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Criteria for gauging response to sodium oxybate for narcolepsy.
    Steffen AD; Lai C; Weaver TE
    J Sleep Res; 2018 Aug; 27(4):e12628. PubMed ID: 29205601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Narcolepsy: pathophysiology and pharmacology.
    Nishino S
    J Clin Psychiatry; 2007; 68 Suppl 13():9-15. PubMed ID: 18078360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expert opinion on pharmacotherapy of narcolepsy.
    Zaharna M; Dimitriu A; Guilleminault C
    Expert Opin Pharmacother; 2010 Jul; 11(10):1633-45. PubMed ID: 20426704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EFNS guidelines on management of narcolepsy.
    Billiard M; Bassetti C; Dauvilliers Y; Dolenc-Groselj L; Lammers GJ; Mayer G; Pollmächer T; Reading P; Sonka K;
    Eur J Neurol; 2006 Oct; 13(10):1035-48. PubMed ID: 16987156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GABAB agonism promotes sleep and reduces cataplexy in murine narcolepsy.
    Black SW; Morairty SR; Chen TM; Leung AK; Wisor JP; Yamanaka A; Kilduff TS
    J Neurosci; 2014 May; 34(19):6485-94. PubMed ID: 24806675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy options for cataplexy.
    Lopez R; Dauvilliers Y
    Expert Opin Pharmacother; 2013 May; 14(7):895-903. PubMed ID: 23521426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.
    Black J; Swick T; Bogan R; Lai C; Carter LP
    Sleep Med; 2016 Aug; 24():57-62. PubMed ID: 27810187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium oxybate for narcolepsy.
    Scharf MB
    Expert Rev Neurother; 2006 Aug; 6(8):1139-46. PubMed ID: 16893342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy.
    Weinhold SL; Seeck-Hirschner M; Nowak A; Hallschmid M; Göder R; Baier PC
    Behav Brain Res; 2014 Apr; 262():8-13. PubMed ID: 24406723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Options for Narcolepsy.
    Barateau L; Lopez R; Dauvilliers Y
    CNS Drugs; 2016 May; 30(5):369-79. PubMed ID: 27155860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.